1. Home
  2. ONBPO vs GRMLW Comparison

ONBPO vs GRMLW Comparison

Compare ONBPO & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONBPO

Old National Bancorp

SELL

Current Price

$25.03

Market Cap

0.0

Sector

Finance

ML Signal

SELL

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.12

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONBPO
GRMLW
Founded
N/A
N/A
Country
United States
United States
Employees
4948
5
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
ONBPO
GRMLW
Price
$25.03
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.5K
15.7K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.53
$0.08
52 Week High
$25.46
$0.38

Technical Indicators

Market Signals
Indicator
ONBPO
GRMLW
Relative Strength Index (RSI) 53.09 29.55
Support Level $24.89 N/A
Resistance Level $25.14 $0.17
Average True Range (ATR) 0.15 0.03
MACD 0.01 -0.01
Stochastic Oscillator 40.18 4.55

Price Performance

Historical Comparison
ONBPO
GRMLW

About ONBPO Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: